2023 annual financial data

Candel Therapeutics 2023 Operating margin

Direct answer

Operating margin was -123,841.94%.

Operating income was -38.39M USD and net income was -37.94M USD.
Operating cash flow was Not available.

Get free Candel Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
31,000 USD
Operating income
-38.39M USD
Net income
-37.94M USD
Operating cash flow
Not available